Statewide

New Jersey Department of Health

Current183 dose entries48 drugs9 documentsNJeffective 2025-08-2198% machine-parsed of 183

New Jersey Department of Health (NJ) carries 48 drugs across 183 dose entries in its current published protocol, effective 2025-08-21.

Drugs and doses48

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1000 mg	IV	not captured	standing	page 75
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	page 75

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV/IO	not captured	standing	page 131
Narrow-complex tachycardia	peds	0.1 mg/kg	IV/IO	not captured	standing	page 131

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2.5 mg	NEB	not captured	standing	page 25
Anaphylaxis	peds	2.5 mg	NEB	not captured	standing	page 25
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 35

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	page 132
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 132
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 120
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 120

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	page 117
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	page 117
Nerve agent exposure	adult	2 mg	IV/IO	not captured	standing	page 59
Nerve agent exposure	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	page 59
Nerve agent exposure	peds	0.05–0.1 mg/kg	IM	not captured	standing	page 61

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	16 mg	SL	not captured	standing	page 87

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	500–1000 mg	IV/IO	not captured	standing	page 117
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	page 117
Hyperkalemia	adult	500–1000 mg	IV/IO	not captured	standing	page 120
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	page 120
Other	adult	1–2 g	IV/IO	not captured	standing	page 152
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 152

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	3–6 g	IV/IO	not captured	standing	page 152
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 152

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	10 mg	IV/IO/IM	not captured	standing	page 22
Adrenal crisis	peds	0.6 mg/kg	IV/IO/IM	not captured	standing	page 22
Asthma / bronchospasm	adult	10 mg	IV/IO/IM	not captured	standing	page 36
Croup	peds	0.6 mg/kg	IV/IM/PO	not captured	standing	page 42

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV	not captured	standing	page 50
Hypoglycemia	peds	0.5 g/kg	IV	not captured	standing	page 50

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	page 59
Nerve agent exposure	adult	5 mg	IV	not captured	standing	page 59
Nerve agent exposure	peds	0.1 mg/kg	IV	not captured	standing	page 59
Other	adult	2 mg	IV	not captured	standing	page 53
Other	peds	0.1 mg/kg	IV	not captured	standing	page 53
Seizure	adult	5 mg	IV	not captured	standing	page 93
Seizure	peds	0.1 mg/kg	IV	not captured	standing	page 93
Seizure	peds	0.1 mg/kg	IO	not captured	standing	page 95

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25 mg/kg	IV/IO	not captured	standing	page 131

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	page 24
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 24
Anaphylaxis	adult	50 mg	IV/IO/IM	not captured	standing	page 25
Anaphylaxis	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 25
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	page 84
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 84
Other	adult	25–50 mg	IV	not captured	standing	page 58
Other	peds	1 mg/kg	IV	not captured	standing	page 58

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5–10 mg	IM	not captured	standing	page 205

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	page 25
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	page 25
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	page 36
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	page 117
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 117
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 119
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 119
Croup	peds	5 mg	NEB	not captured	standing	page 42
Other	peds	5 mg	NEB	not captured	standing	page 41
Sepsis	adult	0.05 mcg/kg	IV/IO	not captured	standing	page 100
Sepsis	peds	0.05 mcg/kg	IV/IO	not captured	standing	page 100

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	1 mcg/kg	IV/IM	not captured	standing	page 75
Severe pain	peds	1 mcg/kg	IV/IM	not captured	standing	page 75

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV/IO	not captured	standing	page 117
Hypoglycemia	adult	1 mg	IM	not captured	standing	page 50
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	page 50
Hypoglycemia	peds	0.5 mg	IN	not captured	standing	page 52

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 205
Agitation	peds	1–3 mg	IM	not captured	standing	page 205

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	peds	2 mg/kg	IV/IM	not captured	standing	page 22

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 107
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 107

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.5 mg	NEB	not captured	standing	page 25
Anaphylaxis	peds	0.5 mg	NEB	not captured	standing	page 25
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	page 35
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	page 35

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	3–4 mg/kg	IM	not captured	standing	page 207
Severe pain	adult	0.25 mg/kg	IV	not captured	standing	page 75
Severe pain	peds	0.25 mg/kg	IV/IO/IM	not captured	standing	page 81
Severe pain	peds	0.5 mg/kg	IN	not captured	standing	page 81
RSI induction	adult	1.5 mg/kg	IV/IO	not captured	standing	page 170
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 214
RSI induction	peds	1 mg/kg	IV/IO	not captured	standing	page 170

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 75
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 75

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20–40 mg	IV	not captured	standing	page 73

Levetiracetam

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	adult	2–4 g	IV	not captured	standing	page 93

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	1 mg/kg	IV/IO	not captured	standing	page 132
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 132
VF / pulseless VT	adult	0.75–1.5 mg/kg	IV/IO	not captured	standing	page 120
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 120

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	IM	not captured	standing	page 205
Nerve agent exposure	adult	1 mg	IV/IO	not captured	standing	page 60
Nerve agent exposure	adult	2 mg	IM	not captured	standing	page 60
Nerve agent exposure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 60
Nerve agent exposure	peds	0.1 mg/kg	IM	not captured	standing	page 60
Other	adult	1 mg	IV	not captured	standing	page 53
Other	adult	2 mg	IM	not captured	standing	page 53
Other	peds	0.1 mg/kg	IV	not captured	standing	page 53
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 91
Other	peds	0.2 mg/kg	IM	not captured	standing	page 53
Post-intubation sedation	adult	1–2 mg	IV/IO	not captured	standing	page 170
Post-intubation sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 170
Procedural sedation	adult	0.5–1 mg	IV/IO	not captured	standing	page 205
Procedural sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 205
Seizure	adult	2 mg	IV/IO	not captured	standing	page 93
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 93

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	page 35
Asthma / bronchospasm	peds	40 mg/kg	IV/IO	not captured	standing	page 35
Eclampsia / pre-eclampsia	adult	4 g	IV	not captured	standing	page 72
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 120
VF / pulseless VT	peds	25–50 mg/kg	IV/IO	not captured	standing	page 120

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	80–125 mg	IV/IO/IM	not captured	standing	page 22
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 22
Anaphylaxis	peds	2 mg/kg	IV	not captured	standing	page 25
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 36

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV/IO	not captured	standing	page 131

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 205
Agitation	peds	0.1 mg/kg	IM	not captured	standing	page 205
Nerve agent exposure	adult	2.5 mg	IV/IN	not captured	standing	page 60
Nerve agent exposure	adult	5 mg	IM	not captured	standing	page 60
Nerve agent exposure	peds	0.2 mg/kg	IV/IN	not captured	standing	page 60
Nerve agent exposure	peds	0.2 mg/kg	IM	not captured	standing	page 60
Other	adult	2.5 mg	IV/IN	not captured	standing	page 53
Other	adult	2.5 mg	IM/IN	not captured	standing	page 91
Other	adult	5 mg	IM	not captured	standing	page 53
Other	adult	5 mg	IM	not captured	standing	page 91
Other	peds	0.1 mg/kg	IV/IN	not captured	standing	page 53
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 91
Other	peds	0.2 mg/kg	IM	not captured	standing	page 53
Other	peds	0.2 mg/kg	IM/IN	not captured	standing	page 91
Other	peds	0.2 mg/kg	IM	not captured	standing	page 91
Post-intubation sedation	adult	2.5–5 mg	IV/IO	not captured	standing	page 170
Post-intubation sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 170
Procedural sedation	adult	1–2.5 mg	IV/IO	not captured	standing	page 205
Procedural sedation	adult	2–2.5 mg	IV/IO/IM/IN	not captured	standing	page 15
Procedural sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 205
Seizure	adult	5 mg	IM/IN	not captured	standing	page 93
Seizure	adult	5 mg	IV/IO	not captured	standing	page 93
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 93
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	page 93

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	0.1 mg/kg	IV/IO/IM	not captured	standing	page 75
Severe pain	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 75

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IV/IO/IM/IN	not captured	standing	page 31
Opioid overdose	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 31

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1 DuoDote	IM	not captured	standing	page 59
Nerve agent exposure	peds	1 DuoDote	IM	not captured	standing	page 59

Nitrous Oxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	Self-administered	NEB	not captured	standing	page 76

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	1–30 mcg	IV/IO	not captured	standing	page 127
Hypotension / shock	peds	0.05 mcg/kg	IV/IO	not captured	standing	page 127
Sepsis	adult	0.05 mcg/kg	IV/IO	not captured	standing	page 100
Sepsis	peds	0.05 mcg/kg	IV/IO	not captured	standing	page 100

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 58
Nausea / vomiting	adult	4 mg	PO/ODT	not captured	standing	page 58
Nausea / vomiting	peds	0.15 mg/kg	IV/IM	not captured	standing	page 58
Nausea / vomiting	peds	2 mg	PO/ODT	not captured	standing	page 58

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1-2 tubes	PO	not captured	standing	page 50
Hypoglycemia	peds	0.5 g/kg	PO	not captured	standing	page 50

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 unit	IM	not captured	standing	page 72

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1–2 g	IV	not captured	standing	page 59
Nerve agent exposure	peds	25–50 mg/kg	IV	not captured	standing	page 59
Nerve agent exposure	peds	25–50 mg/kg	IM	not captured	standing	page 61

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	20–50 mg	IV/IO	not captured	standing	page 132
Wide-complex tachycardia	peds	15 mg/kg	IV/IO	not captured	standing	page 132

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	peds	13.5 mg	NEB	not captured	standing	page 42

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 211
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 214
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 211
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 214

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Tricyclic overdose	adult	1–2 mEq/kg	IV/IO	not captured	standing	page 85
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	page 85

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 211
RSI induction	adult	1.5 mg/kg	IV	not captured	standing	page 214
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 211
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 214

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.25 mg	SQ	not captured	standing	page 36

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	2 g	IV/IO	not captured	standing	page 72
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	page 148

Verapamil

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–10 mg	IV	not captured	standing	page 131

Cite this

New Jersey Department of Health, United States EMS Protocol Census. 183 dose entries, effective 2025-08-21.

https://protoquiz.com/census/agencies/new-jersey-department-of-health/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.